EGFR-Mutant Non-Small Cell Lung Cancer — Year in Review Series on Relevant New Datasets and Advances
Dr Suresh S Ramalingam and Dr Helena Yu discuss the selection and sequencing of therapy for patients with EGFR mutation-positive non-small cell lung cancer and summarize major advances in the treatment landscape reported over the past year. CME information and select publications here.
AI Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from Oncology Today with Dr Neil Love
Oral SERDs for Breast Cancer — Year in Review Series on Relevant New Datasets and Advances
Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancers — Microlearning Activity 3: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium
Prostate Cancer — Year in Review Series on Relevant New Datasets and Advances
Acute Myeloid Leukemia — Year in Review Series on Relevant New Datasets and Advances
Get summaries like this every morning.
Free AI-powered recaps of Oncology Today with Dr Neil Love and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.